Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

National Advertising Division In Brief

This article was originally published in The Tan Sheet

Executive Summary

NAD scrutinizes Colostrum-LD claims

You may also be interested in...



Burner Balm clinical results unveiled

Pacific Shore Holdings' lip balm infused with dietary supplement ingredients for weight management "performed better than anyone expected," says David Toomey, lead investigator in a 12-week, double-blind, placebo-controlled clinical trial involving more than 100 subjects. Los Angeles-based Pacific Shore noted participants using Burner Balm lost an average of seven to nine pounds, many reporting consumption of smaller meals and elimination of snacks. The firm claims the balm's energy-boosting green tea, appetite-suppressing hoodia gordonii, chromium picolinate and caffeine absorb "faster and steadier into the bloodstream" by traveling through blood vessels in the lips. Launching soon to retailers worldwide, Burner Balm sticks are available online at $5.99 apiece

Cosmetic And Personal Care Trademark Review: 16 April

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Health And Wellness Weekly Trademarks Review: 16 April

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS104727

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel